E Fund Management Co., Ltd. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$411
-8.9%
15,293
+20.9%
0.03%
-13.9%
Q2 2023$451
+20.9%
12,646
-13.8%
0.04%
+33.3%
Q1 2023$373
-34.2%
14,679
+5.0%
0.03%
-42.6%
Q4 2022$567
-99.9%
13,978
+13.2%
0.05%
+23.7%
Q3 2022$408,000
-19.2%
12,351
-13.9%
0.04%
-17.4%
Q2 2022$505,000
+71.2%
14,347
+123.4%
0.05%
+360.0%
Q1 2022$295,0006,4210.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,328$51,213,00030.37%
JOHNSON & JOHNSON 3,260,869$203,576,00017.86%
ACT CAPITAL MANAGEMENT, LLC 194,000$12,111,0006.28%
Aquilo Capital Management, LLC 527,926$32,958,0005.99%
Evolutionary Tree Capital Management, LLC 105,491$6,586,0002.92%
ACUTA CAPITAL PARTNERS, LLC 121,500$7,585,0002.68%
L1 Capital Pty Ltd 297,915$18,599,0002.31%
Avidity Partners Management LP 673,700$42,059,0000.93%
Hood River Capital Management LLC 338,734$21,147,0000.65%
Tygh Capital Management, Inc. 64,127$4,003,0000.54%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders